Coxibs Refocus Attention on the Cardiovascular Risks of Non-Aspirin NSAIDs Dixon ThomasZoya AliJason C. Cooper Current Opinion 28 March 2017 Pages: 343 - 346
Teaching an Old Dog New Tricks: Colchicine in Cardiovascular Medicine Kevin ChenAldo L. SchenoneVenu Menon Review Article 28 March 2017 Pages: 347 - 360
The Real Role of β-Blockers in Daily Cardiovascular Therapy Csaba András DézsiVeronika Szentes Review Article Open access 29 March 2017 Pages: 361 - 373
Recommendations for Managing Drug–Drug Interactions with Statins and HIV Medications Barbara S. WigginsDonald G. Lamprecht Jr.Joseph J. Saseen Review Article 01 April 2017 Pages: 375 - 389
Adherence to Treatment, Safety, Tolerance, and Effectiveness of Perindopril/Amlodipine Fixed-Dose Combination in Greek Patients with Hypertension and Stable Coronary Artery Disease: A Pan-Hellenic Prospective Observational Study of Daily Clinical Practice Charalampos I. LiakosDimitrios P. PapadopoulosVasilios T. Kotsis Original Research Article 02 May 2017 Pages: 391 - 398
The Value of Evidence in the Decision-Making Process for Reimbursement of Pharmacogenetic Dosing of Warfarin Andrej JanzicIgor LocatelliMitja Kos Original Research Article 20 May 2017 Pages: 399 - 408
The Ratio of Eicosapentaenoic Acid (EPA) to Arachidonic Acid may be a Residual Risk Marker in Stable Coronary Artery Disease Patients Receiving Treatment with Statin Following EPA Therapy Shigemasa TaniKen NagaoAtsushi Hirayama Original Research Article 20 June 2017 Pages: 409 - 420
